Mapping the Future: 7 Markets Reveal the Infrastructure of the Next Decade (2026-2033)

A cross-sector analysis of MarketsandMarkets forecasts shows where capital, technology, and policy are converging for the decade ahead.

Introduction: Seven Markets as a Lens into the Future

In mid-2026, research firm MarketsandMarkets published a suite of seven market forecasts covering electric vehicle charging stations, zonal autonomous control, quality management system (QMS) software, cell culture, fingerprint sensors, PMMA (polymethyl methacrylate), and crane rental services. Each report is priced at $4,950, and each projects compound annual growth rates (CAGRs) ranging from 3.4% to 17.8% over the 2025–2033 period.

Individually, these are niche analyses. Taken together, they reveal something larger: the physical and digital infrastructure that will underpin the global economy in the next decade. The seven markets span software, hardware, materials, and services, offering a cross-sectional view of how electrification, automation, biotech, and digital transformation are reshaping industries. The common thread is that all these markets either enable or are enabled by sustainability mandates, regulatory complexity, and the push for decentralized control.

[IMAGE: A dashboard-style graphic showing the seven market names with their CAGR values in a radial layout. EV Charging 17.7%, Zonal Autonomous Control 17.8%, QMS Software 11.7%, Cell Culture 12.1%, Fingerprint Sensors 5.7%, PMMA 3.4%, Crane Rental 5.1%.]

High-Octane Growth: EV Charging and Autonomous Control

The two fastest-growing markets in the set are also the most interconnected. The EV charging station market is projected to expand from $38.55 billion in 2026 to $120.85 billion by 2033, a compound annual growth rate of 17.7%. That acceleration is fueled by surging global EV adoption—driven by tightening emissions regulations, falling battery costs, and government subsidies—and by the parallel need to modernize aging grid infrastructure to handle distributed charging loads.

Almost neck-and-neck is the zonal autonomous control market, forecast to grow from $3.15 billion in 2025 to $10.29 billion by 2032 at 17.8% CAGR. Zonal architectures replace traditional distributed ECU networks in vehicles with centralized domain controllers that manage multiple functions—a prerequisite for Level 3+ autonomy. This market’s growth reflects the automotive industry’s shift toward software-defined vehicles and the need for robust, fail-operational control systems.

The key players in both markets overlap significantly. ABB, Siemens, Schneider Electric, and Bosch appear in both the EV charging and zonal control landscapes. This is not coincidental. These industrial and energy giants are converging on a single thesis: the electrification of mobility requires smart grid integration, and smart grids require decentralized, autonomous control at the edge. Together, these two markets signal a massive infrastructure build-out that will consume enormous amounts of steel, copper, semiconductors, and software engineering talent over the next seven years.

[IMAGE: Overlay growth curves of EV charging and autonomous control markets with shared timeline from 2025 to 2033. Both curves show steep upward trajectories, with EV charging reaching ~$120B and zonal control ~$10B.]

The Digital Backbone: QMS Software and Cell Culture – Quality and Life Sciences

The next tier of growth—mid-teens CAGRs—comes from two markets that appear unrelated at first glance but share a deep dependency. The QMS software market is forecast to grow from $11.73 billion in 2026 to $20.43 billion by 2031, a CAGR of 11.7%. Quality management system software automates compliance, document control, audit trails, and nonconformance tracking across regulated industries—especially pharmaceuticals, medical devices, automotive, and food.

Meanwhile, the cell culture market is projected to reach $58.42 billion by 2031 at a 12.1% CAGR. This growth is powered by booming demand for cell-based therapies (CAR-T, stem cell treatments), vaccine production, and monoclonal antibodies. Biopharmaceutical companies are scaling up mammalian cell culture capacity to meet pipeline demands, particularly in Asia and Europe.

The link between the two is straightforward but often overlooked: QMS software is critical for pharmaceutical manufacturing. Any deviation in cell culture production—temperature, pH, contamination—must be documented and investigated under regulatory frameworks (FDA, EMA). As cell culture output multiplies, so does the need for digital quality systems that can handle batch records, electronic signatures, and real-time monitoring. Key players such as Siemens (Opcenter), Veeva (Vault Quality), Honeywell (Lighthouse), and MasterControl serve both regulated manufacturing and life sciences. The forecast figures suggest that spending on quality automation will keep pace with, and in some cases outpace, the biological production itself.

[IMAGE: A split diagram showing a software dashboard (QMS) on one side and a bioreactor (cell culture) on the other, connected by a "quality" link. The dashboard displays compliance metrics while the bioreactor shows cell growth curves.]

Steady but Essential: Fingerprint Sensors, PMMA, and Crane Rental

Not every infrastructure market grows at double-digit rates. Three markets in the set expand at a more moderate pace, yet they provide the materials, components, and heavy lifting capacity that high-growth sectors depend on.

The fingerprint sensor market is forecast to grow at 5.7% CAGR, reaching $6.98 billion by 2032. While the smartphone-driven boom has matured, new applications are emerging: biometric authentication for IoT devices, smart locks, payment terminals, and government IDs. The market is shifting from capacitive sensors to ultrasonic and optical under-display solutions. Growth is steady but no longer explosive, reflecting a technology that has become a commodity enabler rather than a differentiator.

PMMA (polymethyl methacrylate, also known as acrylic glass) is the slowest grower in the set at 3.4% CAGR, to $6.48 billion by 2031. Yet this material is integral to automotive lighting (LED taillight lenses), construction (skylights, signage), medical devices (intraocular lenses, bone cement), and display panels. Its demand is tied to construction activity, vehicle production, and healthcare device manufacturing—all sectors that are themselves expanding. PMMA is also experiencing a shift toward sustainable production, with recycled and bio-based variants gaining traction.

The crane rental market is forecast to reach $71.50 billion by 2031 at 5.1% CAGR. This is the largest market by absolute value in the set, reflecting the sheer scale of global infrastructure and construction activity. Cranes are used in building EV charging stations, erecting wind turbines, constructing biopharma plants, and laying out industrial facilities. The steady growth of crane rental directly supports the high-octane expansion of EV charging and cell culture production. Without crane availability—and the skilled operators to run them—the physical infrastructure boom cannot materialize.

[IMAGE: Horizontal bar chart comparing all seven CAGRs (sorted descending). From left to right: Zonal Autonomous Control 17.8%, EV Charging 17.7%, Cell Culture 12.1%, QMS Software 11.7%, Fingerprint Sensors 5.7%, Crane Rental 5.1%, PMMA 3.4%.]

Hidden Connections and Supply Chain Implications

Looking across the seven forecasts, several cross-market dynamics emerge that are not obvious from any single report.

First, electrification drives demand across the board. EV charging stations require PMMA for durable touchscreens and lighting components, fingerprint sensors for user authentication, crane rental for installation, and QMS software for managing permits, maintenance, and grid compliance. The zonal autonomous control modules inside EVs also rely on fingerprint biometrics for driver identification. These linkages mean that a slowdown in EV adoption would ripple through five of the seven markets.

Second, biopharma expansion is a hidden engine for materials and software. Cell culture growth drives demand for cleanroom construction (crane rental for equipment installation), disposable bioreactor components (PMMA for viewing windows and tubing connectors), and QMS software for batch record management. The forecast data suggests that biomanufacturing capex will remain elevated through 2031, benefiting not just life science companies but also construction, materials, and software providers.

Third, the "slow and steady" markets provide leading indicators. Crane rental growth at 5.1% CAGR is a proxy for global nonresidential construction. If that rate accelerates or decelerates, it will signal capacity constraints or slack in the EV and biopharma build-out. Similarly, PMMA growth at 3.4% reflects underlying industrial production and consumer spending on vehicles and housing. These should not be ignored in favor of the headline-grabbing 17% markets.

[IMAGE: A network diagram showing arrows connecting EV Charging to crane rental, PMMA, fingerprint sensors, and QMS software. Similarly, Cell Culture connects to PMMA, crane rental, and QMS software. The diagram visualizes the supply chain dependencies.]

Key Players: Who Is Positioning Across Markets

The overlap of major corporations across these forecasts is striking. Siemens appears in EV charging infrastructure, zonal autonomous control, and QMS software. ABB is a top player in both EV charging and zonal control. Honeywell straddles QMS software and fingerprint sensor technology. Bosch competes in automotive components (zonal control) and fingerprint sensors. Mitsubishi Chemical and Röhm lead in PMMA production, while Sarens and Liebherr dominate crane rental.

This concentration suggests that the infrastructure of the next decade will be built by a relatively small number of diversified industrial conglomerates. Investors tracking these companies should look beyond their individual segments to the synergies. A company that supplies both charging hardware and the control systems for electric grids is effectively capturing both ends of the electrification value chain. Similarly, a QMS software vendor that also offers manufacturing execution systems for biopharma is positioned to benefit from both quality automation and cell culture scale-up.

Investment and Strategy Takeaways

For procurement managers, supply chain strategists, and investors, these seven forecasts offer a coherent roadmap:

Double down on electrification infrastructure. The combined EV charging and zonal autonomous control markets represent nearly $130 billion in annual spending by the early 2030s. Invest and plan for semiconductor availability, power electronics, and fasteners.
Build biopharma capacity now. The cell culture and QMS software markets are growing at 12% and 11.7% respectively. Any bottleneck in quality compliance software could delay product launches. Digital quality systems should be integrated into the factory design phase, not retrofitted.
Don't neglect the "slow" markets. Crane rental and PMMA will not generate headlines, but they are the physical enablers. A shortage of mobile cranes or a spike in acrylic resin prices could halt an EV charging station rollout as effectively as any chip shortage.
Watch for convergence. The lines between automotive, energy, and life sciences are blurring. A company that builds EV charging stations today may offer grid battery storage tomorrow; a QMS software firm may expand into electronic lab notebooks. Suppliers should position themselves at the intersections.

The next decade will be defined not by any single technology but by the infrastructure that connects them. These seven markets, analyzed together, reveal that infrastructure in sharp relief.

[IMAGE: A world map with highlighted regions showing highest projected growth in EV charging (China, Europe, US), cell culture (US, China, South Korea), and crane rental (Southeast Asia, Middle East).]